Nonpharmacologic treatment of behavioral disturbance in dementia

Medical Clinics of North America

Volumn 86, Issue 3, 2002, Pages 641-656

  Teri, Linda ^a   Logsdon, Rebecca G ^a   McCurry, Susan M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRESSION; AGITATION; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CAREGIVER; DAILY LIFE ACTIVITY; DEMENTIA; DEPRESSION; DIAGNOSTIC ACCURACY; HEALTH CARE PERSONNEL; HUMAN; MEDICAL INFORMATION; MEDICAL LITERATURE; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; PUBLICATION; RATING SCALE; REVIEW; SLEEP DISORDER; SUPPORT GROUP; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; ALZHEIMER DISEASE; CAREGIVERS; DEMENTIA; DEPRESSIVE DISORDER; HUMANS; MENTAL DISORDERS; SLEEP;

EID: 0036323076     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(02)00006-8     Document Type: Review

References (98)

1. The Institute of Psychiatry Alzheimer's disease cohort 1986-1992: Part 1-clinical observations
2. Neuropsychiatric aspects of Alzheimer's disease: The cholinergic hypothesis revisited
3. Assessment of behavioral problems in dementia: The Revised Memory and Behavior Problems Checklist
4. Depression, cognition, and functional ability in patients with Alzheimer's disease
5. Predictors of burden in spouse caregivers of individuals with Alzheimer's disease
6. Caregiver expressed emotion and depression in Alzheimer's disease
7. Management of behavior disturbance in Alzheimer's disease: Current knowledge and future directions
8. Diagnosis and treatment of Alzheimer disease and related disorders: Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society
9. Assessment of agitation in Alzheimer's disease: The Agitated Behavior in Dementia Scale
10. Quantifying behavioral disturbance in Alzheimer's disease patients
11. Treatment of agitation in Alzheimer's disease: A randomized placebo controlled clinical trial
12. A description of agitation in a nursing home
13. The ADCS. Assessing patterns of agitation in Alzheimer's disease patients with the CohenMansfield Agitation Inventory
14. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia
15. Cornell scale for depression in dementia
16. The evaluation of behavioral disturbances in Alzheimer's disease: The utility of three rating scales
17. Review of outcome measurement instruments in Alzheimer's disease drug trials: Psychometric properties of behavior and mood scales
18. A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care
19. Behavioral treatment of depression in dementia patients: A controlled clinical trial
20. NIMH Dementia Mood Assessment Scale (DMAS)
21. Factor structure of the Dementia Mood Assessment Scale in a cohort of community-dwelling elderly
22. Selegiline in the treatment of behavioural disturbance in Alzheimer's disease
23. Development and validation of a Geriatric Depression Screening Scale: A preliminary report
24. Depression in Alzheimer's disease patients: Caregivers as surrogate reporters
25. A rating scale for depression
26. Exercise and activity level in Alzheimer's disease: A potential treatment focus
27. Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment
28. The CERAD Behavior Rating Scale for Dementia (BRSD)
29. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
30. Galantamine for Alzheimer's disease. (Cochrane Review)
31. Diagnosis and treatment of depression in patients with Alzheimer's disease and other dementias
32. Scales for the assessment of Alzheimer's disease
33. The use of psychotropic medication in the management of problem behaviors in the patient with Alzheimer's disease
34. Methodologic issues regarding outcome measures for clinical drug trials of psychiatric complications in dementia
35. Pharmacologic management and treatment of dementia and secondary symptoms
36. Non-cognitive symptoms in Alzheimer's disease
37. Nonneuroleptic treatment of disruptive behavior in organic mental syndromes
38. A community based family/patient group program for Alzheimer's disease
39. A family-behavioral approach to the treatment of the cognitively impaired elderly
40. Behavioral family intervention with the impaired elderly
41. Interventions with care givers of dementia patients: Comparison of two approaches
42. Management of dementia-related behavioral disturbances: A nonpharmacological approach
43. A family intervention to delay nursing home placement of patients with Alzheimer's disease: A randomized controlled trial
44. A randomized trial of family caregiver support in the home management of dementia
45. Treatment for agitation in dementia patients: A behavior management approach
46. An intervention that delays institutionalization of Alzheimer's disease patients: Treatment of spouse-caregivers
47. Interventions for caregivers of patients with Alzheimer's disease: A review and analysis of content, process, and outcomes
48. Treatment of behavioral and mood disturbances in dementia
49. Behavioral treatment of dementia: An overview
50. Frequency and presentation of depressive symptoms in patients with primary degenerative dementia
51. Depression in Alzheimer's patients: Investigation of symptom patterns and frequency
52. Prevalence and incidence of major depression in Alzheimer's disease
53. The Pleasant Events Schedule-AD: Psychometric properties and relationship to depression and cognition in Alzheimer's disease patients
54. Identifying pleasant activities for Alzheimer's disease patients: The Pleasant Events Schedule-AD
55. Evaluating memory wallets in conversations with persons with dementia
56. Assessment of depression in dementia patients: Association of caregiver mood with depression ratings
57. Troublesome and disruptive behaviors in dementia: Relationships to diagnosis and disease severity
58. Falls and fractures in patients with Alzheimer-type dementia
59. Wandering in dementia: A longitudinal study
60. Resident characteristics associated with wandering in nursing homes
61. Wandering behaviour in community-residing persons with dementia
62. Selected psychiatric symptoms associated with rate of cognitive decline in patients with Alzheimer's disease
63. Predictors of mortality in patients diagnosed with probable Alzheimer's disease
64. Survival of outpatients with Alzheimer-type dementia
65. Wandering in a population based Alzheimer's disease patient registry: A significant source of caregiver distress
66. Subjective barriers to prevent wandering of cognitively impaired people. (Cochrane Review)
67. Wandering
68. Visual barriers to prevent ambulatory Alzheimer's patients from exiting through an emergency door
69. Management of patients with Alzheimer's disease in long-term care facilities
70. Patient electronic monitoring system (PEMS)
71. Reducing wandering by persons with dementia using differential reinforcement
72. Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients
73. Predictors of institutionalization for people with dementia living at home with a carer
74. Sleep problems and institutionalization of the elderly
75. Chronic hypnotic use: Deadly risks, doubtful benefit
76. Consensus conference
77. Practice parameters for the nonpharmacologic treatment of chronic insomnia
78. The significance and management of persistent primary insomnia: The past, present and future of behavioral insomnia therapies
79. Approach to sleep disorders in nursing home setting
80. Factors that disturb sleep in nursing home residents
81. Sleep and ageing: The effect of institutionalization on subjective and objective characteristics of sleep
82. Sleep hygiene in physically dependent nursing home residents: Behavioral and environmental intervention implications
83. A randomized trial of a combined physical activity and environmental intervention in nursing home residents: Do sleep and agitation improve?
84. Treatment of sleep disturbance in Alzheimer's disease
85. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients
86. Assessment and management of "sundowning" phenomena
87. Sleep in non-institutionalized Alzheimer's disease patients
88. Roadblocks encountered in recruiting patients for a study of sleep disruption in Alzheimer's disease
89. Sleep disturbances in patients with mild-stage Alzheimer's disease
90. Sleep disorders in geriatric patients
91. Psychiatric morbidity in dementia with Lewy bodies: A prospective clinical and neuropathological comparative study with Alzheimer's disease
92. Alzheimer's disease and related disorders
93. Alzheimer disease and frontotemporal dementias: Behavioral distinctions
94. Behavior and treatment in frontotemporal dementia